Podcasts about skin cancers

In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about: How and when to monitor and treat mild vs severe immune-related toxicitiesThe art of balancing and tapering low-dose and high-dose corticosteroidsDifferentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approachesInvolvement of multidisciplinary teams early during treatment to prevent immune-related adverse eventsImportance of educating patients, caregivers, and providers on immune-related toxicitiesPresenters: Alexa Basilio, PharmD, BCOPUniversity of Florida College of Pharmacy Oncology Pharmacy Specialist McKesson, The US Oncology NetworkTampa, Florida Jessica Davis, PharmD, BCOP, CPP Levine Cancer InstituteClinical Pharmacist Coordinator, Adult Hematology/OncologyAtrium Health Levine CenterCharlotte, North Carolina Link to full program: https://bit.ly/3We4HJy

Please visit answersincme.com/WJM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses strategies for patient-centered management of immune-related adverse events (AEs) in patients receiving immunotherapy for nonmelanoma skin cancer (NMSC). Upon completion of this activity, participants should be better able to: Identify counseling strategies to educate patients and caregivers about AEs related to immunotherapy regimens for melanoma and NMSC; Describe monitoring schedules for short- and long-term immunotherapy-associated AEs; and Outline multidisciplinary management strategies for immunotherapy-associated AEs in dermatologic malignancies. This activity is intended for US healthcare professionals only.

Please visit answersincme.com/WJM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses strategies for patient-centered management of immune-related adverse events (AEs) in patients receiving immunotherapy for nonmelanoma skin cancer (NMSC). Upon completion of this activity, participants should be better able to: Identify counseling strategies to educate patients and caregivers about AEs related to immunotherapy regimens for melanoma and NMSC; Describe monitoring schedules for short- and long-term immunotherapy-associated AEs; and Outline multidisciplinary management strategies for immunotherapy-associated AEs in dermatologic malignancies. This activity is intended for US healthcare professionals only.

IANR 2433 0817124 Line Up 4-6pm INTERVIEWS (Guest host Sridhar Kotha) Here's the guest line-up for Sat, August 17, 2024 from 4 to 6pm CST on Indo American News Radio (www.IndoAmerican-news.com), a production of Indo American News. We are on 98.7 FM and you can also listen on the masalaradio app (www.masalaradio.com) By Monday, hear the recorded show on Podcast uploaded on Spotify, Apple Podcasts, Pocket Casts, Radio Public and Breaker. We have 5 years of Podcasts and have had over 10,400 hits. TO SUPPORT THE SHOW, SELECT FOLLOW ON OUR FREE PODCAST CHANNEL. AND YOU'LL BE NOTIFIED WHEN OF NEW UPDATES. 4:20 pm This weekend, starting on Thursday, August 15 through Sunday, August 18, the Ashtalakshmi Temple on Synott Rd. officially inaugurates the giant 90-foot statue of Hanuman which will be visible from miles away. Made of bronze, it is located in a clearing on the temple site and is the tallest statue of Hanuman in the US. Once again, we turn to temple Board members Dr. Ravi Timarisa and his brother, Dr. Chary Timarisa to tell us how this project was envisioned and details of the ongoing festivities. 5:00 pm In the brutal summer sun of Houston, we are all advised to use plenty of sunscreen on exposed parts of the body. Yet a simple task like driving in short sleeves can give your left arm a tan and we think nothing about it. Skincare can be crucial as the body ages, but what works best on South Asians, who are also more susceptible to skin cancers? Dr. Tejas Desai of Heights Dermatology joins us today to explain what some common skin problems are and how to treat them. 5:30 pm The rape and murder of a 31 year-old doctor in Kolkata, India at the government run RG Kar Medical College on August 9 has led to waves of protests and strikes all across the nation with demands of justice and more safety procedures. It has also galvanized many outraged Houstonians and we turn to Sayoni Bhattacharya, Dinesh Adhikari and Mondakini Chatterjee from the Bengali community for their reaction. Also stay tuned in for news roundup, views, sports and movie reviews. TO BE FEATURED ON THE SHOW, OR TO ADVERTISE, PLEASE CONTACT US AT 713-789-NEWS or 6397 or at indoamericannews@yahoo.com Please pick up the print edition of Indo American News which is available all across town at grocery stores. Also visit our website indoamerican-news.com which gets 70,000+ hits to track all current stories. And remember to visit our digital archives from over 16 years.  Plus, our entire 43 years of hard copy archives are available in the Fondren Library at Rice University. --- Support this podcast: https://podcasters.spotify.com/pod/show/indo-american-news-radio/support

Effective partnerships between dermatologists and oncologists are an essential component of care coordination for patients with advanced non-melanoma skin cancers. This interprofessional collaboration can be more challenging in the community setting, where fewer resources are available in comparison to large academic medical centers. In this podcast episode, CANCER BUZZ speaks with Emily Smith, MD, associate professor of Dermatology at St. Louis University School of Medicine, about best practices for early referral from dermatology and how to identify high-risk patients.     “It's impossible to read through every single journal that comes out every single day. There are really nice email listservs that [community] providers can sign up for that will provide updates—the American Academy of Dermatology host[s] guidelines for the care and management of different cancers: cutaneous squamous cell carcinoma [and] basal cell carcinoma being two of them, and they are updated on a cyclical basis. Those are great guidelines to just ensure…that they are reviewed and that current practices are following those guidelines.”—Emily Smith, MD Emily Smith, MD  Associate Professor of Dermatology   Department of Dermatology   St. Louis University School of Medicine   St. Louis, MO    This podcast was made possible with support from Regeneron. Resources ACCC: Advanced Non-Melanoma Skin Cancers - Effective Practices in Multidisciplinary Care  Oncodermatology Society  American Academy of Dermatology issues new guidelines for treatment of nonmelanoma skin cancer 

Featuring perspectives from Dr Evan J Lipson, including the following topics: Introduction: Johns Hopkins University (0:00) Metastatic Melanoma (8:21) Nonmetastatic Melanoma and Other Skin Cancers (34:20) CME information and select publications

Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers.

Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Skin).

In this episode our ever-curious hosts, Doctor Nigel and Professor Jonathan, dive deep into the ‘sunny side' of skin health, shedding light on the multifaceted impact sunlight has on your body. The Docs embark on a comprehensive discussion about the perils of ultraviolet (UV) radiation. With a particular focus on the alarming rise of skin cancer cases in the sun-drenched land of Australia, they highlight how the country's love affair with the sun has led to it being dubbed the "skin cancer capital of the world."How do sun rays affect the skin differently? The Docs delve into the nitty-gritty of UV radiation, explaining how UVA and UVB rays penetrate the skin, causing everything from red-hot sunburns to DNA damage. While a tan might make you look like a bronzed god or goddess, it is actually could be your skin crying out for help.What are the key components of the Australian "5 S's" campaign? The conversation takes a hopeful turn as they explore the effectiveness of various preventative measures. The Docs praise the Australian "Slip, Slop, Slap, Slide, and Seek" campaign, which encourages people to slip on a shirt, slop on sunscreen, slap on a hat, slide on sunglasses, and seek shade. They also give some sun-sational advice, discussing the importance of using broad-spectrum sunscreens with high SPF, reapplying sunscreen every two hours, and wearing protective clothing. The Docs then emphasise the critical importance of early detection in combating skin cancer. They share personal anecdotes about friends and family members who have undergone skin checks, some of whom discovered potentially dangerous lesions just in the nick of time. Professor Jonathan quips that while it might feel like a game of "spot the difference," regular skin checks can be lifesaving. The Docs stress the need for listeners to adopt sun protection strategies diligently and to perform regular skin checks. They advise seeking medical advice for any skin concerns, no matter how trivial they may seem, because when it comes to skin health, it's better to be safe than sorry. As they wrap up, they remind everyone that while the sun might be a star, your skin should be the real star of the show, deserving all the care and protection it can get.—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship.To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocsFollow us on: x.com/JoinTheDocs

Featuring perspectives from Dr Nikhil I Khushalani and Dr Jason J Luke, including the following topics: Introduction (0:00) Evidence-Based Treatment of Nonmetastatic and Metastatic Melanoma — Dr Luke (2:49) Optimizing the Management of Nonmelanoma Skin Cancers — Dr Khushalani (36:54) CME information and select publications

Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/PostASCO2024/Skin).

Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers.

In this episode, I discuss skin health appearance and why both are important indicators of the health status of your immune system, gut microbiome, and other organ systems. I explain why sunlight is essential for skin and hormone health and how excessive sunlight can accelerate skin aging and cause certain skin cancers. I discuss the different types of sunscreens (physical, chemical, and mineral-based) and potential health concerns of the chemicals found in some (but not all) sunscreens. I also discuss the importance of getting your skin (and not just moles) checked for pre-cancerous and cancer growths, the role of nutrition and lifestyle factors that improve skin health and appearance, and how to improve your skin by reducing local and systemic inflammation and supporting your microbiome.  I explain what works to improve your skin's youthfulness and appearance, including reducing wrinkles, sagging, and pore size. I review the data on ingesting (or topically applied) collagen, vitamin C, niacinamide, hyaluronic acid, and retinol, and what is known about the use of peptides (e.g., BPC-157, copper peptides) and red and far-red light phototherapies for improving skin health and appearance. I also discuss the causes of acne, rosacea, and psoriasis and explain nutritional, skin care, and prescription-based approaches to treating these common skin conditions. This episode ought to help everyone better understand the biology of the skin and help them make the best possible decisions for their skin health, care, and appearance according to age, goals, and current skin conditions. Access the full show notes, including referenced articles, books, people mentioned, and additional resources at hubermanlab.com. Andrew's New Book Protocols: An Operating Manual for the Human Body: https://protocolsbook.com Thank you to our sponsors AG1: https://drinkag1.com/huberman Joovv: https://joovv.com/huberman BetterHelp: https://betterhelp.com/huberman  ROKA: https://roka.com/huberman  LMNT: https://drinklmnt.com/huberman  Timestamps 00:00:00 Skin Health 00:02:59 Sponsors: Joovv, BetterHelp & ROKA  00:07:18 Skin Biology, Skin Layers 00:12:40 Sun Exposure, UV Light & Skin Cancers; Sunscreen 00:19:51 Aging, Sun Exposure, Skin Cancers, Physical Barriers 00:27:24 Sunburn & Skin Cancers 00:30:09 Sponsor: AG1 00:31:58 Vitamin D, Sun Exposure & Sunscreen 00:36:50 Organic (Chemical) Sunscreen & Inorganic (Mineral-Based) Sunscreen 00:49:20 Skin Cancers, Moles, Laser Resurfacing 00:53:59 Sponsor: LMNT 00:55:34 Sun Exposure, Melanoma & Life Expectancy 01:03:13 Tool: Youthful Skin, Collagen & Vitamin C 01:12:55 Peptides, BPC-157, Copper 01:20:58 Tool: Niacinamide (Nicotinamide), Youthful Skin, Dark Spots, Hyaluronic Acid 01:26:25 Tool: Retinol (Retin-A, Tretinoin, Retinyl Esters), Youthful Skin 01:33:07 Tool: Phototherapy, Youthful Skin, Treating Skin Conditions 01:41:10 Tool: Nutrition for Skin Health, Anti-Inflammatory Diets 01:47:54 Highly Processed Foods, Advanced Glycation End Products & Skin Health 01:52:08 Tools: Reduce Inflammation: Gut Microbiome, Sleep, Alcohol, Smoking, Stress 01:58:58 Acne, Hormones & Insulin; Tool: Low Glycemic Diet, Dairy 02:07:26 Tools: Face Cleansing & Acne; Scarring & Popping Pimples 02:13:29 Tool: Treating Rosacea, Alcohol, Skin Care, Nutrition 02:18:31 Stubborn Rosacea, Over Cleansing, Pulsed Dye Laser 02:21:04 Psoriasis Treatment, Immune System & Prescriptions 02:25:24 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer

Episode 69 - A way to detect Skin Cancers early and chats with exhibitors at the Everything Electric Show. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Head of SunSmart at the Cancer Council Victoria, Emma Glassenbury, says Victorians need to be vigilant from the end of August to the end of April, when UV levels typically rise above three.See omnystudio.com/listener for privacy information.

Nina G. Jablonski is an American anthropologist and palaeobiologist who's work focusses on the social and biological meanings of skin color in humans. She completed her PhD in Anthropology in 1981 and she is currently an Evan Pugh University Professor at Pennsylvania State University. Her work spans broad yet intimately connected topics such as human evolution, human diversity, and racism. She was recently elected to the U.S. National Academy of Sciences and in 2009, she was elected to the American Philosophical Society.-Nina is the author of several books including “Living Color: The Biological and Social Meaning of Skin Color”, and “Skin: A Natural History” which examine the biological basis of skin pigmentation as well as the sociocultural implications of varying degrees of melanin density.- Timestamps00:00:00 - Intro00:01:32 - How Nina Started Studying Skin00:11:45 - The Goldilocks Zone of UV Exposure00:16:22 - Evolutionary Depigmentation Events00:22:58 - Discussing Skin Pigmentation in the Medical Field00:28:37 - Balancing Sun Exposure in Our Unnatural World00:31:42 - Vitamin D or Sunlight?00:39:32 - Epidemiology of Skin Cancers & Public Health Messaging00:44:33 - How Pigmentation Impacts Addictive Behaviour Patterns00:48:22 - Color-Based Discrimination00:58:08 - Dissecting Race & Culture with Regard to Identity01:01:28 - Importance of Early Childhood Education01:05:08 - Categorical Thinking & Minimal Group Paradigm Bias01:07:20 - Nina's Current Projects01:09:19 - Hair in Human Culture01:12:59 - Outro-Follow Nina HereWebsiteBooks-Follow My WorkWebsiteConsultationInstagramYoutubeSpotifyApple PodcastsLinkedinLinktree

In this podcast, Professor John Paoli discusses his research on skin cancer, including melanoma and non-melanoma types. He emphasizes the significance of prevention, early detection, and effective treatment options, such as basal cell carcinoma. Listeners will gain valuable insights on educating patients about protecting themselves from skin cancer and providing optimal care in case of diagnosis. Dermatologists seeking to stay current on skin cancer research and best practices should not miss this valuable episode.   Link to video version: https://www.eadvlearning.org/pages/53/podcast   You are invited to participate in our survey to improve the show. Your feedback is valued and appreciated to allow us to better serve our audience: https://eadv.org/eadv-podcast-survey/

Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson, including the following topics: Introduction: Immunology of Melanoma (0:00) Melanoma (8:26) Cutaneous Squamous Cell Carcinoma (43:15) Basal Cell Carcinoma and Merkel Cell Carcinoma (52:55) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 2: Localized Melanoma and Other Types of Skin Cancer — Evan J Lipson, MD CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers | Faculty Presentation 1: Metastatic Melanoma — Omid Hamid, MD CME information and select publications

Featuring a discussion on the most impactful updates from 2022 in the management of melanoma and nonmelanoma skin cancers with Dr Omid Hamid and Dr Evan J Lipson, moderated by Dr Neil Love.

Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson moderated by Dr Neil Love. Produced by Research to Practice. CME information and select publications here (http://www.researchtopractice.com/YiR2022/SkinCancers).

Welcome to another episode of Safety Shorts, in which Libby is joined by Dr. Lynne Morrison, a renowned medical dermatologist with over 30 years of experience. Today's focus is on the importance of skincare, particularly in preventing skin cancer as Dr. Morrison shares valuable insights into recognizing it early, as well as the risks associated with sun exposure. She also highlights the significance of practicing sun protection, sharing the story of a remarkable patient who exemplifies the effectiveness of best practices in this area. For everyone who works outdoors, and, really for anyone who wants to maintain healthy skin, today's episode provides essential information and practical tips you simply can't afford to miss.   Episode Highlights: Dr. Morrison emphasizes the need for regular skin examinations and awareness of changing moles or new spots that persist The case study of a patient with an inherited disease underscores the power of sun protection in preventing skin cancer Practical tips are provided for reducing sun exposure, such as avoiding midday sun and utilizing sunscreen and protective clothing The episode addresses the challenges faced by workers who are exposed to the sun during peak hours and the importance of implementing proper sun protection measures Dr. Morrison's expertise and personal experiences shed light on the significance of skincare and the positive impact of practicing sun protection Toolbox Talk Discussion Questions:   In this episode, Dr. Morrison talks about the importance of catching skin cancers early. How can we relate catching health risks early to the rest of our safety practices? We can't always avoid midday sun, but how can we add sunscreen and sun protective clothing into our regular routines? Does anyone have an experience with skin cancers that they'd like to share? Quotes: "Skin cancers usually occur in middle-aged to older individuals on sun-exposed areas of their skin." "Catching melanoma early is really important. If it's diagnosed and treated when it's early, it is entirely curable." "The main thing we can do to prevent skin cancer is to reduce the amount of sun we get." "Sun protection actually works. She is an amazing example of living with a challenging disease and she does show us that sun protection actually works." "Practicing good skin protection, including wearing sunscreen and the right PPE, will really help, especially for workers exposed to the sun during peak hours." Links: National Stone, Sand & Gravel Association website

Welcome to our podcast series discussing treatment-related adverse events with enfortumab vedotin in the management of locally advanced or metastatic urothelial carcinoma. In this second episode, we discuss the management of skin reactions associated with enfortumab vedotin, or EV. Our Guests:In this episode, Dr. Normand Blais, who is a medical oncologist and Director of clinical research in thoracic oncology at the CHUM and adjunct professor at McGill University in Montreal, QC interviews dermatology specialist, Dr. Joel Claveau. Dr. Joel Claveau is a dermatologist specializing in the diagnosis and treatment of Melanoma and Skin Cancers, and an Associate Professor with the Department of Medicine at Laval University guides us through this discussion. This podcast episode was sponsored by Seagen Canada.If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com.

Welcome to our podcast series discussing treatment-related adverse events with enfortumab vedotin in the management of locally advanced or metastatic urothelial carcinoma. In this first episode, we discuss the evolution of therapy from chemotherapy to treatment with novel therapies such as enfortumab vedotin, or EV. We then focus on the key clinical trials examining the efficacy and safety of EV for the treatment of urothelial carcinoma. Our Guests:We introduce the topic in our first episode with Dr. Normand Blais, who is a medical oncologist and Director of clinical research in thoracic oncology at the CHUM and adjunct professor at McGill University in Montreal, QC. Dr. Joel Claveau, a dermatologist specializing in the diagnosis and treatment of Melanoma and Skin Cancers, and an Associate Professor with the Department of Medicine at Laval University guides us through this discussion. This podcast episode was sponsored by Seagen Canada.If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com.

This episode features an interview with Cody Simmons, CEO of DermaSensor, a health technology company that aims to launch the world's first point-and-click skin cancer detection tool for primary care providers. The skin cancer evaluation tool, also called DermaSensor*, is a point-and-click device that can provide health care practitioners with a skin evaluation in seconds.  As a bioengineer and entrepreneur, Cody has spent all of his career bringing new health technologies to physicians and patients. Prior to joining DermaSensor, Cody led commercial efforts for a Silicon Valley medical device screening and monitoring startup. He began his career in business development and commercial strategy roles at Genentech.Hear more about the innovative technology and application of DermaSensor in this episode. And view a video excerpt of the device in action here: https://youtu.be/4-NnRcyOFHcRead more at: Clinical Studies Support DermaSensor's Skin Cancer Detection Device*FDA submission pending review. DermaSensor is currently not for sale in the United States.References1. Merry SP, Croghan I, McCormick B, Chatha K, Leffell D. Clinical Performance of Novel Elastic Scattering Spectroscopy (ESS) in Detection of Skin Cancer: A Blinded, Prospective, Multi-Center Clinical Trial [Initial Results]. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022.2. Carli P, Nardini P, Crocetti E, De Giorgi V, Giannotti B. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res 2004;14(5):403-407.3. Soyer H, Argenziano G, Zalaudek I, Corona R, Sera F, Talamini R, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology. 2004;208:27-31.4. Stanganelli I, Serafini M, Bucch L. A cancer-registry-assisted evaluation of the accuracy of digital epiluminescence microscopy associated with clinical examination of pigmented skin lesions. Dermatology. 2000;200(1):11-16.5. Dinnes J, Deeks JJ, Grainge MJ, et al. Visual inspection for diagnosing cutaneous melanoma in adults. Cochrane Database of Systematic Reviews. 2018;12:CD013194.6. Data on File, DermaSensor Inc.7. Seiverling EV, Agresta T, Cyr P, Caines L, Nguyen VL, Chatha K, Siegel DM. Clinical Utility of an Elastic Scattering Spectroscopy Device in Assisting Primary Care Physician's Detection of Skin Cancers. Poster Presentation, Maui Derm Hawaii Conference, Wailea, HI, January 24-28, 2023. For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

For sun worshippers and people who just weren't vigilant about using sunscreen, two types…

For Educational Purposes. The Artists and Creators own their music/songs and content. ☆☆Potential link: Nail Salons and Skin Cancers.☆☆

As the southern hemisphere basks in summer's beautiful warmth, Michael and Josh skip the beach to explore skin cancer. While melanoma usually takes centre stage in the oncological world, it is far less common than basal cell carcinoma or squamous cell carcinoma. Metastatic squamous cell carcinoma now has a viable and effective treatment option called cemiplimab. At the other end of the spectrum, Michael investigates the very rare cancer type Merkle Cell Carcinoma and how Avelumab has changed its treatment paradigm. Once again, it's immunotherapy at its best. So remember, while listening to our podcast, don't forget to wear a hat and apply sunscreen generously!Links to studies discussed in this episode (subscription may be required):Migden et al. (Cemiplimab): https://www.nejm.org/doi/10.1056/NEJMoa1805131?url_ver=Z39.88JAVELIN Merkel 200 (Cohort B): https://jitc.bmj.com/content/9/7/e002646For more episodes, resources and blog posts, visit inquisitiveonc.comFind us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlexiAction: https://pixabay.com/users/alexiaction-26977400/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice. Hosted on Acast. See acast.com/privacy for more information.

Associate Professor Dr David Francis, President of the Australian College of Dermatologists, joined Joe Hildebrand to talk about skin cancers and summer skin care.See omnystudio.com/listener for privacy information.

This is not medical advice, and I am not a doctor, I'm sharing what I do, for educational purposes only. This is what my family has done for at least...

Do you know what skin cancer is? How you get it? Can you name at least one skin cancer? While most people are familiar with melanoma, there are actually 2 much more common skin cancers out there. On this podcast I'm interviewing dermatologist and skin cancer expert, Dr. Nicole F. Velez from Pittsburgh Skin, where we take a deeper dive into the 3 most common skin cancers out there.  www.pittsburghskin.com @pittsburghskin

Skin cancer is the abnormal growth of skin cells. Most often it develops because of skin exposure to the sun. But this common form of cancer can also occur on the areas of skin not ordinarily exposed to sunlight. There are three major types of skin cancer — basal cell carcinoma, squamous cell carcinoma and melanoma. we can reduce the risk of skin cancer by limiting or avoiding exposure to ultraviolet (UV) radiation. Checking our skin for suspicious changes can help detect skin cancer at its earliest stages. Early detection of skin cancer gives us the greatest chance for successful skin cancer treatment. Listen to this episode to know more about skin cancers. Hope this helps. Jai Hind

Dr. Meredith McKean discusses the importance of skin cancer screenings. Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma. Dr. Meredith McKean discusses molecular profiling and driver mutations in patients with melanoma.A huge thank you to our sponsors #Merck and #Exelixis!For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

Brian Gastman, MD, Surgical and Co-Director of Cleveland Clinic's Melanoma and High-Risk Skin Cancer Program joins the Cancer Advances podcast to discuss Merkel cell carcinoma (MCC). Listen as Dr. Gastman discusses clinical trials exploring the use of immunotherapy with adoptive cell transfer for advanced melanoma and Merkel cell carcinoma.

In this episode, we take a close look at advanced non-melanoma skin cancer. With advances in detection, diagnosis and treatments for both melanoma and non-melanoma, these cancers are being discovered at earlier stages and treated with a much more personalized approach. With us today to talk specifically about advanced non-melanoma skin care are two experts in the field: Dr. Gregory Biedermann and Dr. Christos Papageorgiou.

In this episode, we take a close look at advanced non-melanoma skin cancer. With advances in detection, diagnosis and treatments for both melanoma and non-melanoma, these cancers are being discovered at earlier stages and treated with a much more personalized approach. With us today to talk specifically about advanced non-melanoma skin care are two experts in the field: Dr. Gregory Biedermann and Dr. Christos Papageorgiou.

Dr. Shannon M Clark discusses melanoma, other skin cancers and how to protect yourself with Dermatologist, Dr. Jennifer Deaver of The Pearl Dermatology, Houston, TX @thepearldermatology. --- Support this podcast: https://anchor.fm/adoctordeliverspodcast/support

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Interview with Mackenzie R. Wehner, MD, MPhil, author of Risks of Multiple Skin Cancers in Organ Transplant Recipients: A Cohort Study in 2 Administrative Data Sets

Interview with Mackenzie R. Wehner, MD, MPhil, author of Risks of Multiple Skin Cancers in Organ Transplant Recipients: A Cohort Study in 2 Administrative Data Sets

According to the website skincancer.org, 1 in 5 Americans will develop skin cancer by the age of 70. An increase in awareness in skin cancer is significant since the link between UltraViolet exposure and skin cancer is well established. A lot of people especially during summer holidays bathe in the sun for long periods not knowing that it could pose a risk in the development of skin cancer. Of course there are other factors to consider that contributes to its development but I think it is useful for all of us to be aware about skin cancer so that we can be vigilant enough in having it checked when needed for prevention purposes. ////// Email: NursetalksIG@aol.com

Deepti Kallam, MD (USMD Red Bird Square Oncology and Infusion Center) talks with WellMed Radio co-hosts Dr. Marissa Charles and veteran broadcaster and attorney Ron Aaron Eisenberg about the diagnosis and treatment of skin cancers. Listen to the podcast here https://www.podbean.com/media/share/pb-f846y-10d41a9 or by searching for WellMed Radio in Apple Podcasts, Google Podcasts, Podbean, Pandora, Stitcher and Spotify. WellMed Radio focuses on health issues affecting adults. Clinicians and partners discuss stories, topics and tips to help you live healthier. WellMed Radio airs on Sundays in Tampa at 1:30 p.m EST on AM 860/FM 93.7 The ANSWER and in San Antonio at 6 p.m. CST at KLUP. Visit us at www.wellmedhealthcare.com.

Deepti Kallam, MD (USMD Red Bird Square Oncology and Infusion Center) talks with WellMed Radio cohosts Dr. Marissa Charles and veteran broadcaster and attorney Ron Aaron Eisenberg about the diagnosis and treatment of skin cancers. See omnystudio.com/listener for privacy information.

Overview: In this episode, we learn about advanced melanoma; in particular stage III and IV melanoma, and the different kinds of gene mutations and why they are important.  Later in the episode we will talk about different treatment options for melanoma.   Speakers: Professor Grant McArthur is a Fellow of the Royal Australasian College of Physicians and holds a Ph.D. in Medical Biology. He is the Executive Director of the Victorian Comprehensive Cancer Centre and inaugural Lorenzo Galli Chair of Melanoma and Skin Cancers at the University of Melbourne. He is also Head of the Molecular Oncology Laboratory, Cancer Research, and a Senior Consultant Medical Oncologist, Cancer Medicine at the Peter MacCallum Cancer Centre. Associate Professor David Gyorki is a consultant surgical oncologist at the Peter MacCallum Cancer Centre, specialising in the management of patients with melanoma and soft tissue sarcoma. He is also the Research and Education Lead in Melanoma and Skin Cancer at the Victorian Comprehensive Cancer Centre.   Topics Covered In This Episode: What is stage III and stage IV melanoma What tests are performed to diagnose stage III and stage IV melanoma What is a biopsy How does melanoma spread throughout the body The types of treatment options for advanced melanoma What are the different gene mutations and why are they important Development and effectiveness of immunotherapy What is targeted therapy and how does it work When is immunotherapy utilised How does radiotherapy differ from other treatments What is adjuvant therapy and what is the role of drug therapy What is neoadjuvant therapy   For More Information: The Spot On Podcast is brought to you by the Melanoma & Skin Cancer Advocacy Network (MSCAN) - who are providing a new, innovative approach to tackle Australia's national cancer. MSCAN engages with Australia's leading clinicians, researchers and advocates with the aim of increasing the knowledge of those affected by a diagnosis.  MSCAN is grateful to the clinicians interviewed in our podcast series. They have all provided their time and input freely and independently.  The content discussed in these episodes is for information purposes only and should not be considered as medical advice. Please make sure you speak with a medical professional for advice relating to your own specific situation.  

In this Healthed lecture,Dr O'Connor, Radiation Oncologist; GenesisCare, explains that radiotherapy can be a safe and effective alternative to surgery, and is particularly useful for the elderly or where surgery might have a negative impact on function or cosmesis. It may be used as definitive treatment for low-risk cancers, as an adjuvant treatment for high-risk disease or alone for inoperable cases. This lecture will explain the types of RT, pros and cons in comparison to surgery, which kinds of cancer are suitable and provide some guidelines for GPs on when to refer patients for consideration of radiotherapy. See omnystudio.com/listener for privacy information.

There are many forms of skin cancer, some better known than others. In this episode of our special series Spotlight on Skin Cancer, we are going to take a look at two forms of advanced skin cancer: advanced basal and squamous cell skin cancers. Joining us for this conversation are Dr. Robert Ferris and Dr. Emily Smith.

There are many forms of skin cancer, some better known than others. In this episode of our special series Spotlight on Skin Cancer, we are going to take a look at two forms of advanced skin cancer: advanced basal and squamous cell skin cancers. Joining us for this conversation are Dr. Robert Ferris and Dr. Emily Smith.

In this episode, Dr. Erica Lacher and show host Justin Long discuss various skin cancers, including squamous cell carcinoma, sarcoids, and melanoma. Topics include signs and diagnosis, treatment, and prevention. 

In this episode, we were joined by surgical oncologist Dr. Carolyn Nessim (www.twitter.com/carolynnessim). Dr. Nessim works at the Ottawa General Hospital and gave us a masterclass on melanoma. We talk about an initial approach to melanoma, staging, immunotherapy, and a walk-through of how Dr. Nessim does her groin dissections. Links 1. http://carolynnessim.com/ 2. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033/ 3. Cordeiro et al. Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/26932710/ 4. Socioeconomic Status and Melanoma in Canada: A Systematic Review. https://pubmed.ncbi.nlm.nih.gov/32955341/ Brief Bio: Dr. Carolyn Nessim is a Surgical Oncologist at the Ottawa Hospital and Assistant Professor of Surgery at the University of Ottawa. She completed her MD, MSc (Biomedical Sciences) and General Surgery Residency at the University of Montreal. Her fellowship training was in Surgical Oncology at the University of Toronto and then at the Peter MacCallum Cancer Center in Melbourne Australia. She is currently also a Clinician Investigator in the Cancer Therapeutics Program at The Ottawa Hospital Research Institute (OHRI) as well as the Program Director for the Complex Surgical Oncology Subspecialty Fellowship training program. Her clinical practice focuses on the treatment of patients with Soft Tissue Sarcoma/GIST, Melanoma/Skin Cancers, Gastric cancer and Neuroendocrine Tumours. She is the Regional Co-Lead for Melanoma and Skin Cancers and Gastric Cancer in the Champlain LHIN. She has been invited as a speaker and moderator at several national and international conferences on the topics of Sarcoma and Melanoma. She is a member of Cancer Care Ontario's Skin Cancer Advisory Board as well as the American Society of Clinical Oncology's Technical Expert Group for Melanoma.

Medical Advisor for Melanoma UK and Clinical Lead for Skin Cancer at the Royal Stoke University Hospital, Wayne Jaffe, joins #YouMeBigC. Kate Cochrane also joins Debs, Lauren and Steve to talk about her experiences of having melanoma. Don't forget, you can get in touch by using the #YouMeBigC across all forms of social media - spread the word and share the positive support.

17th November 2020: The Aftermath of the storm - what happened at Tanya & Steve's house? Rockin Recorder Ruesday - Men at Work. Doping in swimming - JR's Spin on Sport and Shayna Jack. Peter Overton (Channel 9) tells Tanya & Steve his Melanoma scare. See omnystudio.com/listener for privacy information.

We are joined this week by Dr Sarah Bell, a dermatology consultant from ULHT who talks through the most common skin cancers - BCC and SCC, with your host Dr Rachel Saville.

In this Healthed lecture, Specialist Plastic Surgeon - Dr Joe Dusseldorp explains why facial cancers require a number of special considerations starting from the biopsy technique itself, and the fact that lesions in certain parts of the face are prone to recurrence. Current techniques in facial reconstruction allow for very minimal scarring, which is something patients always worry about.  See omnystudio.com/policies/listener for privacy information.

Basal and squamous skin cancers are the most common skin cancers that are not melanomas. Stanleur Capital: Medical practice and personal financial solutions

Basal and squamous skin cancers are the most common skin cancers that are not melanomas.

HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.   These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.   In this episode of HOPA Now, Dr. Laura Alwan highlights the fundamentals of melanoma skin cancers, including current statistics and risk factors, the epidemiology of melanoma, common genetic mutations, and advances in the treatment of metastatic disease. She concludes with a look at the relationship between melanoma and the immune system and offers a brief overview of genetic mutations and other considerations for non-melanoma skin cancers.   In this episode you will learn:   An overview of melanoma and non-melanoma skin cancers Diagnosis, death rates, common causes and other statistics for melanoma Genetic variability is increasing in melanoma subtypes, including cutaneous and non-cutaneous melanomas. Risk factors can be identified and summarized with the ABCDE acronym. Targeted immunotherapies are changing traditionally low metastatic melanoma survival rates. The pathophysiology of melanoma lesions, starting with genetic mutations from the melanoma transition Immune surveillance examines the relationship between melanoma and the immune system while immune targeted theory has improved the disease response rate and overall survival rates. Common genetic mutations in melanoma and current testing options for high-risk patients Genetic mutations and other considerations for non-melanoma cancers   Mentioned in This Episode: HOPA   Quotes:   “Most patients are diagnosed with early-stage disease, and only 4–5% are diagnosed with metastatic disease at the time of presentation.” — Laura Alwan   “The primary risk factor for melanoma is ultraviolet light exposure.” — Laura Alwan   “Melanoma is thought to have a close and unique relationship with the immune system.” — Laura Alwan  

HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.   These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.   In this episode of HOPA Now, Dr. Laura Alwan shares ten clinical pearls regarding melanoma skin cancers, including immunotherapy as a main treatment option in melanoma cancers, management of related adverse events, and other patient considerations for immunotherapy. She also highlights specific considerations for select immune-related adverse events, offers timelines for high dosage steroids, and details treatment options for unique melanoma cancers.   In this episode you will learn:   Melanoma skin cancer treatments Immunotherapy as a main treatment option in melanoma cancers The when and how of immune-related adverse events Data and symptoms surrounding PD1 inhibitors and CTLA4 inhibitors, including dose-related toxicities How to monitor and manage immune-related adverse events Specific considerations for select immune-related adverse events, including rapid GI transit Timelines for managing high dose steroids Treatment and management options for patients with BRAF mutations Unique therapy for melanoma through the use of T-VEC   Mentioned in This Episode: HOPA   Quotes:   “Melanoma is known to have a high degree of somatic mutations and has a unique relationship with the immune system.” — Laura Alwan   “It’s important for the oncology pharmacist to consider if infection prophylaxis is warranted.” — Laura Alwan  

Most people have heard of a skin disease called melanoma, a deadly cancer that can affect children and adults alike.   Do you know anything about what triggers this tumor and, more importantly, do you know how to lower your children's lifetime risk of ever developing this horrible disease? Stay tuned as we discuss all of this in this installment of Portable Practical Pediatrics Image by Pixabay Musical Intro Summer Means Fun in the Sun As I post this podcast, we just celebrated Memorial Day 2020, the beginning of summer when we start enjoying meals with family and friends, long summer days,  beach trips, and most significantly, the warmth of the summer sunshine.  All that sounds great but there is a darker side to the long days of sun, however. All that lovely sunshine may cause enough skin damage to initiate an extremely dangerous skin cancer called melanoma in your children- years after the sunburn-especially if the sun damage comes in the form of a blistering sunburn.  In fact, just one blistering sunburn in a young child doubles their chance of melanoma in their lifetime.  The more burns, the more risk. But while melanoma makes up just 10% of all types of skin cancer, it causes the overwhelming majority of skin cancer-related deaths. It is the gorilla in the room when it comes to skin cancer deaths, even in children.  So, let's explore this cancer a little closer, shall we? What is Melanoma: Skin cancers come in a variety of types, but the most deadly form is a cancer of the pigment producing cells in the skin called melanoma, the cells that give your children's skin color by producing a pigment called melanin. These pigment producing cells are located very close to the surface of your children's skin and are therefore quite susceptible to damage from the UV rays of the sun. You would think that children with darker skin, and therefore more melanin, would be more likely to develop melanoma, but the opposite is true. The children most likely to eventually develop melanoma are those that have very pale skin, who burn in the sun rather than tan. Other risk factors for melanoma are a child having a high numbers of moles, freckles, red hair, blue eyes, as well as a family history of melanoma. Fair skinned children have dearth of pigment which allows the high energy UV sun rays to penetrate more deeply into the child's skin and cause DNA damage that can trigger melanoma. In fact, melanoma, is thought to have a wider variety of genetic mutations than any other type of human cancer and these gene mutations are mostly caused by exposure to sunlight-especially when your child is young. In other words, melanoma is a disease triggered by damage from sunlight in genetically susceptible-fair skinned children and adults. And most importantly, it is preventable! Melanoma Good News But there is some good news when it comes to melanoma in children. From 2006 to 2015, the number of melanoma cases  in teens, in the US has actually decreased by about 5% after decades of rising. This is great news! This means that the preventative steps that public health advocates, pediatricians, and dermatologists have been stressing are being taken seriously and have been implemented by parents. We want this trend to continue, and hopefully we’ll also see this trend in adult cases. Unfortunately, the most recent research shows that  adult cases of melanoma continue to increase but maybe that will change soon as well. How Do Parents Prevent Melanoma in their Children? So, we now know that melanoma and other skin cancers are mostly preventable, especially if that prevention starts early a child's life. But how does a parent make sure their children are protected? Here is my list of action points for you to commit to memory and start implementing if you have not already done so: Use Sunscreen: This likely comes as no surprise. Sunscreen of 15 SPF or greater has been proven to be an effective way of protecting yourself from ...

Holistic and Integrative Physician and Surgeon, Gastón Cornu-Labat, MD graduated from Facultad de Medicina, Universidad de Buenos Aires, Argentina in 1991. He obtained his specialty title in general surgery from Northeastern Ohio Universities College of Medicine in Youngstown, Ohio in 2001 to then specialize in liver and pancreatic surgery at Virginia Mason Medical Center in […] The post Dr Gaston Cornu-Labat discusses BEC-a non-invasive very successful treatment for Skin Cancers. appeared first on Holistic Health Show.

Skin cancer is common in the head and neck area because of exposure to ultraviolet (UV) radiation from the sun. Dr. Jonathan Giurintano discusses the most common types of skin cancers and how we treat them.   TRANSCRIPT Intro: MedStar Washington Hospital Center presents Medical Intel where our healthcare team shares health and wellness insights and gives you the inside story on advances in medicine. Host: We’re speaking with Dr. Jonathan Giurintano, a head and neck cancer surgeon at MedStar Washington Hospital Center. Thank you for joining us, Dr. Giurintano. Dr. Giurintano: Thank you so much for having me today. Host: Today we’re discussing treatment options for skin cancers of the head and neck. Dr. Giurintano, how common are skin cancers of the head and neck compared to skin cancers that affect other areas of the body? Dr. Giurintano: Skin cancers in the head and neck region are extremely, extremely common. The most common types of skin cancers (these are basal cell carcinomas, squamous cell carcinomas and melanomas), are found in areas of the body that receive exposure to the UV radiation from the sun. As the head and neck are the most frequently sun-exposed areas of the body, it follows that these are also extremely common areas that we see skin cancers, often occurring on the scalp, the face, the ears, nose, cheeks or on the neck. Host: In less visible areas of the body, cancerous moles, spots and other tissues often are removed. How do you approach treatment of the very visible tissue of the head and neck? Dr. Giurintano: So, it’s similar to other areas of the body, especially for larger skin cancers. The best treatment is typically surgical excision. Our colleagues, the dermatologists, are often times specially trained to perform a procedure called Mohs micrographic surgery. So, this is actually a very special type of surgery in which the skin cancer is removed and normal appearing skin around the periphery of the skin cancer, and this is sectioned by the dermatopathologist and looked at under the microscope at the time of the surgery to confirm that there is no further cancer cell present. By doing this, the dermatologists are able to not only completely excise all cancerous cells from the region of the skin cancer, but oftentimes are able to limit the amount of normal skin that must be sacrificed in order to completely resect the skin cancer. In areas such as the nose, the ears or the cheeks, there oftentimes is not much elasticity to the skin that allows for the defect in the skin to be closed simply. Other times, the defect might be closed simply, however the resultant scar might result in an unattractive cosmetic appearance. So, for these types of patients, we do have special ways that we can rearrange the tissue on the face in order to not only reconstruct the defect left behind by the resection of the skin cancer, but also do so in a way that the scar is camouflaged and has the most cosmetically appealing appearance.    Dr. Giurintano: Well, basal cell and squamous cell carcinoma are the most common types of skin cancers that we treat. Other skin cancers such as melanoma require different types of treatment. Host: What makes treatment different for melanoma? Dr. Giurintano: So, one of the concerning features of melanoma is that we really cannot do Mohs micrographic surgery for melanomas. Whereas Mohs surgery relies on freezing the samples of normal skin from around the periphery of the tumor and looking at that sample under the microscope with very good success rates for ruling out the presence of cancerous cells, we know that that technology does not work quite as well for melanoma cells. As a result, most melanomas require pretty large resections. So, not only do you excise the melanoma itself, but oftentimes we excise at least one centimeter of normal appearing tissue around the periphery of the melanoma up to two centimeters of normal appearing tissue, dependent on how deep the melanoma is traveling underneath the skin. So, what initially starts out as a very small defect in the face, might soon become a defect that measures 4 or 5 centimeters and needs a major reconstruction. Another facet of melanoma is that it tends to spread very easily to lymph nodes in the neck. So, anytime patients have a melanoma in the head and neck region, very commonly we want to know what is the status of the lymph nodes in the neck. One of the special tools we have for helping determine the lymph node status in the neck is something called sentinel lymph node biopsy. So, this is a special procedure where, on the day of the surgery, before the melanoma is removed, the area around the melanoma is actually injected with a dye that has kind of a radioactive uptake. And then after the melanoma is excised, we can then actually go down to the neck and determine where the lymph nodes are that that melanoma was draining to. So, instead of having to do a large incision to take out all the lymph nodes in the neck without knowing if any of the lymph nodes are positive, we can actually pinpoint only one or two lymph nodes that we know the melanoma would have most likely been draining to and we can go take those lymph nodes out and then look at those lymph nodes under the microscope. And if those lymph nodes do not have any evidence of melanoma, then we know that it’s generally safe to watch the neck and not perform any major surgery or give any other therapeutic treatments. So, if that lymph node is involved with tumor, then we could go into the neck, make the incision larger and do a complete neck dissection or complete removal of the lymph nodes in the neck to help prevent recurrence of the melanoma in the future. Host: Can these cancers spread to other parts of the body? Dr. Giurintano: Yes. So, that is where my job as a head and neck cancer surgeon often takes the most importance in treating patients with skin cancers. For some people, they might have a small skin cancer on the scalp or on the ear. This is removed by a Mohs surgeon, with negative margins. The area is closed, the patient’s happy, and then 5 or 6 months down the road, that patient might develop a small lump in the parotid gland or in the neck. In short, yes, these skin cancers can also send metastasis to the lymph nodes in the face and lymph nodes in the neck. And whenever these lymph nodes do occur, they can often become very aggressive and distort the tissue surrounding them. So, my job as a head and neck surgeon in dealing with skin cancers, often occurs once the skin cancer has spread or metastasized to lymph nodes. And my job is to go into the neck or into the parotid gland and to remove these lymph nodes to remove all the cancer that has spread. Host: How do you recommend that patients prepare for treatment? Dr. Giurintano: A large part of the preparation for these patients is mental and emotional. Oftentimes, when the Mohs surgeon performs their portion of the procedure, which is the removal of the skin cancer, the resultant defect might be left in place with a bandage over it so that they can then be reconstructed secondarily by an otolaryngologist or by a facial plastic surgeon. It can be very distressing for patients to see a large hole in their face immediately after surgery, but they must be assured that this will be reconstructed in a manner that is both cosmetically appealing and functional. Occasionally, in order to repair defects in the skin on some parts of the nose, we have to take tissue from adjacent sites on the face, such as the skin on the forehead, and use that skin to resurface the lining of the nose. In order to do that sort of procedure, what’s called a local tissue flap, the patient has a very odd appearance immediately after surgery as the piece of skin still has a bridge connecting it where the artery, that is supplying the skin flap, is running. This can result in a very strange physical appearance for the 3 to 4 weeks immediately after reconstructive surgery while the skin is healing in to place on the nose. However, we have to encourage the patient that within 6 weeks, a second procedure is performed where that skin bridge is removed, and the remaining tissue is reoriented so that there is a normal cosmetic appearance with only a minor scar present on the forehead. Host: What does recovery from head and neck skin cancer treatment entail? Dr. Giurintano: So, aside from the actual recovery from surgery, which is often performed either on an outpatient basis or maybe with a 1 to 2 day hospital stay, if the lymph nodes in the neck need to be removed, recovery from head and neck skin cancer treatment, most importantly, requires a very close follow-up, with either an otolaryngologist or a dermatologist, in the future to ensure that no other areas of skin cancer arise within the head and neck. While it is impossible to completely reverse the many decades of damage the UV radiation from the sun has often done to patients’ skin, it is never too late to begin applying sunscreen and to do precautionary measures to help limit the amount of damage to the remaining skin and to help prevent further skin cancers from occurring in the future.  Host: You mentioned sunscreen. Are there any other prevention tips that you can offer to people in the community? Dr. Giurintano: So, aside from wearing sunscreen daily, which should be part of all of our daily routines anytime we go out - the face, the ears, and, especially for men who might be balding, application of sunscreen on the scalp, a few other very good preventative measures are to wear a wide brimmed hat if you are going to be out in regular sun exposure and to not only apply sunscreen whenever it’s sunny outside. Even if it’s cloudy outside, the UV radiation from the sun can still cause damage to the skin, so sunscreen in encouraged and recommended anytime patients are going to be outside.  Host: Could you share a story about a patient who had a particularly successful outcome after skin cancer treatment? Dr. Giurintano: So, I previously had a patient who was actually a transplant patient - previously had a kidney transplant - and, as part of his transplant protocol, he was required to take immunosuppressive drugs to ensure that the body did not reject the transplanted kidney. The unfortunate thing about immunosuppressive drugs is that if a cancer does develop in the body, the immune system is not present to help fight that cancer and it can spread very rapidly. So, I previously had a patient who was a transplant recipient, who developed what was initially a very small skin cancer present on his left face that very rapidly increased in size, to the point where nearly the entirety of his left face was involved with the skin cancer within only a few weeks. This patient required a large radical resection of the tumor as well as the underlying parotid gland and the lymph nodes in the neck. In this patient, we actually used a free flap (so, that’s a piece of tissue from the thigh that we connected with an artery and a vein in the neck), and we used that tissue from the leg to resurface the skin, fat and parotid gland that was resected during the cancer resection. And, the patient had an excellent cosmetic appearance afterwards and was able to complete radiation therapy and chemotherapy, and since that time, has not had any further skin cancers develop. Host: Why is MedStar Washington Hospital Center the best place for patients to come to receive treatment for skin cancers of the head and neck? Dr. Giurintano: MedStar Washington Hospital Center is an excellent place to come for head and neck skin cancer treatment as we have all the tools necessary to handle the most minor skin cancers up to the most complicated of skin cancers. While many small skin cancers can be handled in the community setting, for those type skin cancers which become very aggressive and which might invade locally into structures of the face - this includes the muscles of the face, the parotid gland or the large saliva glands on the side of the face and even the facial nerve, the nerve that controls all facial movements on one side of the face -  for all these patients, even if the tumor is involving these structures, we have the surgical capability as well as the capability to provide adjuvant radiation therapy and chemotherapy, for even the most aggressive skin cancers to help patients have not only the best oncologic outcome possible but also the best cosmetic and physical outcome possible. Host: Thanks for joining us today, Dr. Giurintano. Dr. Giurintano: It was a pleasure. Thank you so much for having me. Conclusion: Thanks for listening to Medical Intel with MedStar Washington Hospital Center. Find more podcasts from our healthcare team by visiting medstarwashington.org/podcast or subscribing in iTunes or iHeartRadio.

Reconstructive Surgery for Melanoma and Skin Cancers with guest Dr. James Clune March 24, 2019 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Reconstructive Surgery for Melanoma and Skin Cancers with guest Dr. James Clune March 24, 2019 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

There is a veritable zoo of things that can grow on your skin. From freckles to skin cancers, tonight we discuss these things - and we discuss the treatments from peels to surgery.We also discussed peels in different skin colors - from lunch hour peels to laser peels. We discussed how peels were first discovered to be beneficial to the skin and how they evolved from an observation about flame burns to hundreds of high tech machines that are designed to shrink skin and build up collagen.

Reconstructive Surgery for Melanoma and Skin Cancers with guest Dr. James Clune March 24, 2019 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Marc Brown, MD, stopped by the Dermcast studios during the SDPA’s Annual Summer Dermatology Conference 2018, held in Seattle, Washington, to discuss non-melanoma skin cancers.

In this episode Jonathan talks about skin cancers and moderate plus profile breast implants. #AskJJ

​​He's been on our podcast several months ago, and also last week, but Dr Robert Bard of the Bard Cancer Center in NYC is back yet again. On this episode Dr Maulfair and Dr Bard discuss these subjects and more: "Gopher Cancer" and "Rodent Carcinoma" How every single hour, one person dies from malignant melanoma in the US How only 1 out of every 33,000 moles biopsied turns out to be a melanoma​​ Robert L Bard, MD, PC, DABR, FASLMS is internationally known and recognized as a leader in the field of 21st Century 3D ULTRASONOGRAPHIC VOLUMETRIC DOPPLER IMAGING. Dr Bard specializes in advanced 3D sonography to detect cancers in numerous organs including the breast, prostate, skin, thyroid, melanoma, and other areas. If you're not in Pennsylvania, but are looking to find a doctor like Dr Maulfair, you can search for one in your area by going to The International College of Integrative Medicine (http://icimed.com)

In this episode we talk about the Sun, Sunscreens, Skin Cancers, look at a Common Procedure, spin the Wheel of Medicine and take 3 Shots. We hope you join us as we dive deep into medicine so you don't have to. We present the best studies and research in easy to understand and entertaining ways. We gladly accept show topics and ideas from our listeners.

Dr Testorri speaks with ecancer at EADO 2017 about preserving patient quality of life with loco-regional control of disease. He highlights the considerations of how best relieve patients of disease burden without unnecessary damage to healthy tissue, especially when lesions and scars would be highly visible. Dr Testorri reports successes with combining immune therapies with surgical interventions, and describes how electrochemotherapy can improve cytotoxic uptake into cancer cells.

Welcome to the " Dr. Fred Says " BTR Radio Show   ...   LIVE today at 12 NOON - CST  Today's Show is all about Summertime, Skin Cancers and how essential oils can benefit. Each Wednesday, Dr. Valdes - along with his associate Dlynn Saumer - brings us up-to-date information on the state of health in the world today. Presently Dr. Valdes teaches part-time at a medical school close to Miami. His background is emergency medicine and he has spent many years studying complementary medicine. Within his team are doctors, chiropractors. therapists, alternative health care practitioners and professional athletes.

City of hope is a leader in the diagnosis and treatment of skin cancers and precancerous conditions.. Our multidisciplinary team of health care professionals take an integrated approach to treating this disease by combining the latest research findings with outstanding patient care.Do you know the warning signs of skin cancer?If we are using more sunscreen as a nation, why are skin cancers on the rise? What are some of the risk factors? Who is most at risk? Is there anything more we can do to protect ourselves from skin cancer?As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in research and treatment of skin cancer.Joining the show is Hans Schoellhammer, M.D. Surgical Oncologist at City of Hope, to help you avoid skin cancer and learn the facts.

ELIZABETH PLOURDE, C.L.S., NCMP, Ph.D., is a Menopause Practitioner, medical researcher, health educator, and Internationally known author whose books: EMF Freedom: Solutions for the 21st Century Pollution and Sunscreens Biohazard: Treat as Hazaardous Waste reveal how to reduce the health impact of wireless devices and alternatives to the sunscreens that can lead to the skin cancers they were intended to prevent. The cell phones and Wi-Fi  we are now surrounded by create a variety of symptoms including headaches, insomnia, itchy skin rashes, dizziness, nausea, and heart palpitations.  Essential for everyone, Dr. Plourde offers simple, inexpensive techniques for cell phone and Wi-Fi Radiation survival in today’s electrified world, as well as safer sun exposure.     JJ Flizanes is an Empowerment Strategist. She is the Director of Invisible Fitness, an Amazon best-selling author of Fit 2 Love: How to Get Physically, Emotionally, and Spiritually Fit to Attract the Love of Your Life, and author of Knack Absolute Abs: Routines for a Fit and Firm Core. She was named Best Personal Trainer in Los Angeles for 2007 by Elite Traveler Magazine.     JJ vividly reminds us that the word ‘fitness’ is not just about the state of one’s physical body, but also the factors which determine a person’s overall well being.   And, for JJ, the key components in all these areas are ‘invisible’ — balanced support structures of nutrition, emotional centeredness and health. A favorite of journalists and the media for her depth of knowledge and vibrant personality, JJ, a contributing expert for Get Active Magazine, has also been featured in many national magazines, including Shape, Fitness, Muscle and Fitness HERS, Elegant Bride, and Women’s Health as well as appeared on NBC, CBS, Fox 11 and KTLA. She is also a video expert for About.com and regular contributor for The Daily Love.   JJ launched her professional career in 1996 as the Foundations Director for the New York Sports Club, where she designed curriculum and in-house certification for new and previously uncertified fitness trainers. She has also been certified by the American Council on Exercise (ACE), International Sports Science Association (ISSA), and the Resistance Training Specialist Program (RTS).   With a focus on biomechanics, JJ has lectured for The Learning Annexand as a featured speaker for New York Times Bestselling Author of The Millionaire Mind, T. Harv Ecker’s Peak Potentials seminars, as well as corporate clients, including Pacific Gas and Electric, Hanson Engineering, and Jostens, Inc. She is the Wellness Expert for KFC International, the Health and Fitness Expert for the National Association of Entrepreneur Moms, and a Fitness Expert for Nourishing Wellness Medical Center.    She has been working in the health and wellness industry for 15 years, as a fitness trainer with a knack for helping her clients become more self-aware and self-empowered through her ability to quickly identify and pinpoint problem areas, and then create simple solutions involving exercise, nutrition and mindset changes. She is the Host of the new iTunes Podcast Show Fit 2 Love: Physical, Emotional and Spiritual Fitness for the Happy Life You Deserve which is six day a week video and audio show.   What sets JJ apart from her Celebrity Fitness counterparts is the holistic approach to getting results. Over the last fourteen years she has studied, used and applied Positive Psychology, Neuro-Linguistic  Programming (NLP), Eye Movement Desensitization and Reprocessing (EMDR), Emotional Freedom Technique (EFT), Law of Attraction, Quantum Physics, Non Violent Communication, Imago Therapy, and Hypnotherapy. JJ Flizanes has proven that she’s not only an expert in matters of the body and fitness—she’s an insightful and provocative author who delivers a timely message about matters of the heart.  

On the Wednesday June 11th 2014 at 1:30PM Pacific/4:30PM Eastern our special guest is noted melanoma expert Edward McClay, MD.Dr. McClay is making an encore appearance on the show, for our earlier chat, click here.'Dr. McClay is a recognized nationally as a leader in Melanoma treatment and clinical research. Born and raised in Philadelphia, Dr. McClay served as a staff sergeant in the US Air Force. He received both his B.A and M.D. degree from Temple University, graduating in 1980. He completed a Residency in Internal Medicine and a Fellowship in Medical Oncology at Thomas Jefferson University, where he was subsequently appointed to the faculty as an Assistant Clinical Professor. Dr. McClay has held several positions in academic medicine, including Associate Professor and Medical Director at the Medical University of South Carolina, Hollings Cancer Center, and Professor of Medicine and Director of Clinical Affairs at the University of California, San Diego (UCSD) Cancer Center.Dr. McClay continues his special interests in malignant melanoma and brain tumors. He co-authored the book 100 Questions and Answers about Malignant Melanoma and other Skin Cancers with his wife, Mary-Eileen. They have been married for over 30 years and have two children.'Join us! 

On the Wednesday June 11th 2014 at 1:30PM Pacific/4:30PM Eastern our special guest is noted melanoma expert Edward McClay, MD.Dr. McClay is making an encore appearance on the show, for our earlier chat, click here.'Dr. McClay is a recognized nationally as a leader in Melanoma treatment and clinical research. Born and raised in Philadelphia, Dr. McClay served as a staff sergeant in the US Air Force. He received both his B.A and M.D. degree from Temple University, graduating in 1980. He completed a Residency in Internal Medicine and a Fellowship in Medical Oncology at Thomas Jefferson University, where he was subsequently appointed to the faculty as an Assistant Clinical Professor. Dr. McClay has held several positions in academic medicine, including Associate Professor and Medical Director at the Medical University of South Carolina, Hollings Cancer Center, and Professor of Medicine and Director of Clinical Affairs at the University of California, San Diego (UCSD) Cancer Center.Dr. McClay continues his special interests in malignant melanoma and brain tumors. He co-authored the book 100 Questions and Answers about Malignant Melanoma and other Skin Cancers with his wife, Mary-Eileen. They have been married for over 30 years and have two children.'Join us! 

This podcast is on Treatment and Diagnosis of Actinic Keratosis and NonwithMelanoma Skin Cancers with Linda Susan Marcus, MD and was recorded at the 2013 SDPA Fall Conference in Atlanta.

This interview is on Carcinoma Treatment with Jaeyoung Yoon MD and was recorded at the 2013 Summer SDPA Conference in St. Louis.

Medical Grand Rounds with Faramarz H. Samie, MD, PhD

A study in the November issue of Gastroenterology looks at the risk of nonmelanoma skin cancer (NMSC) among individuals with inflammatory bowel disease (IBD). Dr. Kuemmerle speaks to study co-author Dr. Harminder Singh

Audio podcast from the 8th Annual SDPA Fall Dermatology Conference in Grapevine, TX. This was “Common Skin Cancers: An Approach to Diagnosis and Treatment.” This session is also available as a download on iTunes through the dermcast podcast page*. Click here to visit the page on iTunes. *Please note that [...]

Dr. Peter O'Brien outlines the how to deal with skin cancers.